Genmab A/S Files 6-K with Updated Articles of Association
Ticker: GNMSF · Form: 6-K · Filed: Jun 18, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-governance
TL;DR
Genmab filed a 6-K with updated Articles of Association, incorporated into its S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on June 18, 2025, to report updates. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File No. 333-284876. The report includes Exhibit 3.1, which contains the company's Articles of Association.
Why It Matters
This filing ensures that investors have access to the most current governing documents of Genmab A/S, which is crucial for understanding the company's structure and operations.
Risk Assessment
Risk Level: low — This is a routine administrative filing that incorporates existing documents, posing no new or immediate risks.
Key Players & Entities
- Genmab A/S (company) — Registrant
- June 18, 2025 (date) — Filing Date
- 333-284876 (registration_statement) — Incorporated by reference
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the filing date of this report?
The filing date of this report is June 18, 2025.
Which registration statements does this 6-K filing get incorporated into?
This 6-K filing is incorporated by reference into Genmab A/S's registration statements on Form S-8, specifically File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What exhibit is included with this filing?
Exhibit 3.1, which is the Articles of Association, is included with this filing.
What is the principal executive office address of Genmab A/S?
The principal executive office address of Genmab A/S is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 18, 2025 regarding GENMAB A/S (GNMSF).